Category : Pharmaceuticals


Top FDA Drug Official Resigns Amid Federal Probe

The FDA's principal deputy commissioner, Dr. Namandjé Bumpus, resigns following federal probe into undisclosed concerns about her conduct, marking significant leadership shakeup.

Kimberly-Clark Buys Tylenol Maker in $48.7B Deal

In a landmark move reshaping the consumer healthcare landscape, Kimberly-Clark announces its acquisition of Kenvue, the company behind Tylenol and other household brands, in a staggering US$48.7 billion transaction that creates a new industry powerhouse.

Blood Pressure Medication Recall Over Cancer Risk

Health Canada issues urgent recall for specific blood pressure medications containing potentially carcinogenic nitrosamine impurity. Learn which lots are affected and what steps to take.

Boehringer Ingelheim Licenses Novel Autoimmune Treatment

Global pharmaceutical leader Boehringer Ingelheim secures exclusive license from Kyowa Kirin to develop innovative autoimmune disease treatment, targeting conditions like lupus and rheumatoid arthritis with novel therapeutic approach.

Kamloops Pharmacist Suspended, Fined $2,500

A Kamloops pharmacist faces consequences after admitting to making false statements to their regulatory body, resulting in a four-month suspension and financial penalty.

Page 1 of 1